Local Treatment of Metastatic Melanoma With Autologous Lymphocytes and the Bispecific Antibody rM28
Clinical trial NCT00204594 · COMPLETED
Trial details
- NCT number
- NCT00204594
- Sponsor
- University Hospital Tuebingen
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-10-01
- Primary completion
- 2007-12-01
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.